fbpx Skip to main content

THURSDAY, Feb. 11, 2021 (HealthDay News) — Adults with congenital heart defects (CHDs) are more likely to report cardiovascular comorbidities than those in the general population, according to research published in the Feb. 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Using data from 1,482 respondents in the 2016 to 2019 Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being, Matthew E. Oster, M.D., from the CDC in Atlanta, and colleagues estimated the prevalence of comorbidities among adults with CHDs aged 20 to 38 years born in Arizona, Arkansas, and metropolitan Atlanta compared with the general population.

The researchers found that compared with adults in the general population, those with CHDs, especially those with severe CHDs, were more likely to report cardiovascular comorbidities, including a history of congestive heart failure (4.3 versus 0.2 percent) and stroke (1.4 versus 0.3 percent). The likelihood of reporting current depressive symptoms was increased for adults with CHDs (15.1 versus 8.5 percent), but they were less likely to report previous diagnoses of depression (14.2 versus 22.6 percent), asthma (12.7 versus 16.9 percent), or rheumatologic disease (3.2 versus 8.0 percent). Adults whose CHD was considered severe and those with nonsevere CHDs had a similar prevalence of noncardiovascular comorbidities.

“These findings can inform providers, policy makers, patients, and families of the expectations and needs of a growing population of adults with CHDs,” the authors write.

Abstract/Full Text

You May Also Like::  Decrease Seen in Non-COVID-19-Related Hospitalizations at Peak

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More